Deadline: July 31, 2026
QVAR Inhaler Antitrust Settlement 2026 -- File a Claim by July 31
By eosguide editorial · Last updated
Teva's $35M QVAR antitrust settlement is open. Bought QVAR or QVAR Redihaler between 2015--2025? File your claim by July 31, 2026. Turns out a decade of brand-name inhaler prices may have had a cheaper generic waiting in the wings -- Teva allegedly made sure you'd never find out.
Deadline: July 31, 2026
File Your Claim →
Applies to
Alaska, Arkansas, Arizona, California, Connecticut, Delaware, District of Columbia, Florida, Hawaii, Illinois, Indiana, Iowa, Kansas, Maine, Massachusetts, Maryland, Michigan, Minnesota, Mississippi, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Rhode Island, South Dakota, Tennessee, Texas, Utah, Virginia, Vermont, Washington, West Virginia, Wisconsin, Wyoming
Main deadline
July 31, 2026
Benefit
A pro-rata cash payment from a $35 million settlement fund -- exact amount depends on your purchases and the total number of valid claims filed.
Official site
https://qvarantitrustsettlement.com
What happened
Class period: January 1, 2015 through July 31, 2025
- Plaintiffs allege that Teva Pharmaceutical manipulated the FDA's patent registration system -- known as the "Orange Book" -- by listing patents for QVAR inhalers that did not meet legal listing requirements, making it easier for Teva to block generic competitors from entering the market
- Teva also allegedly discontinued certain QVAR inhaler versions and switched to reformulated products to obtain fresh patent protection over the new versions, a tactic known as "product hopping"
- These strategies allegedly delayed generic alternatives from reaching pharmacy shelves, forcing consumers and health plans to continue paying inflated brand-name prices for years longer than they should have
- The class period covers purchases made from January 1, 2015 through July 31, 2025
- Teva denies all allegations; no court has ruled on the merits of the claims
What you can get
Cash payment
Pro-rata share
Amount varies based on purchase volume and total valid claims filed
Key dates
| Action | Date | What it means |
|---|---|---|
| Claim deadline | July 31, 2026 | Last day to file a claim |
| Opt out | June 15, 2026 | Keep your right to sue separately |
| Object | June 15, 2026 | Tell the court you disagree |
| Final hearing | August 5, 2026 at 2:00 p.m. Eastern -- check qvarantitrustsettlement.com for any date or location changes | Judge decides whether to approve |
Who may qualify
- Purchased, paid for, or reimbursed the cost of QVAR or QVAR Redihaler inhalers between January 1, 2015 and July 31, 2025
- Purchases were made in one of the eligible states or D.C. listed above
- Products were purchased for personal, family, or beneficiary consumption -- not for resale
- Health plans, insurers, and other third-party payors that reimbursed members for QVAR purchases may also qualify under a separate claim process
- You are not Teva, a Teva affiliate, a federal or state government entity, or someone who has already excluded yourself from the class
How to file
- Visit the official settlement website at qvarantitrustsettlement.com and click "File a Claim"
- Individual consumers should complete the Consumer Claim Form; health plans and insurers should complete the Third-Party Payor Claim Form
- Submit your claim online by July 31, 2026, or download the paper form, complete it, and mail it postmarked no later than July 31, 2026, to: QVAR Antitrust Settlement, c/o A.B. Data, Ltd., PO Box 173034, Milwaukee, WI 53217
Filed this claim?
Save the claim ID, deadline, payout notes, and official link in the free Settlement Claim Tracker. It stores entries in your browser, with no account needed.
Add to Tracker →Want the next deadline before it sneaks past you?
Get weekly settlement alerts: new settlements, upcoming deadlines, and claim tips once a week.
No spam. Unsubscribe anytime.
Proof required
- No specific proof of purchase is listed as required for individual consumer claims -- you will be asked to provide your purchase information on the claim form
- Third-party payors must provide documentation supporting their purchases, payments, or reimbursements for QVAR products during the class period
- Retaining any receipts, insurance records, or pharmacy documentation you have may be helpful; review the claim form instructions at qvarantitrustsettlement.com for full details
Payment timing
Payments will be distributed after the Court grants final approval of the Settlement and any appeals are resolved. Payment method has not yet been specified -- check qvarantitrustsettlement.com for updates.
Important links
Contact
Phone: 866-588-8524
Email: info@QVARAntitrustSettlement.com
Mail: QVAR Antitrust Settlement, c/o A.B. Data, Ltd., PO Box 173034, Milwaukee, WI 53217
Extra details
- As part of the settlement, Teva has agreed to request removal of certain QVAR patents from the FDA's Orange Book -- a step that could help clear the way for generic versions to reach the market going forward
- This lawsuit is not about the safety or effectiveness of QVAR or QVAR Redihaler products; those issues are not part of this case
- Consumer identities are kept confidential throughout the claims and exclusion process
- You can file a claim even if you also file an objection to the settlement -- the two actions are independent
- If you do nothing, you will receive no payment and will lose your right to sue Teva separately for these claims
FAQ
Who qualifies for the QVAR inhaler antitrust settlement?
You may qualify if you purchased, paid for, or reimbursed the cost of QVAR or QVAR Redihaler inhalers in one of the eligible states between January 1, 2015 and July 31, 2025, for personal, family, or beneficiary consumption (not for resale). Health plans, insurance companies, and other third-party payors that covered QVAR costs for their members may also qualify under a separate claim process.
How much will I receive from this settlement?
The exact amount is not yet known. Individual consumers share proportionally in 20.7% of the net settlement fund, based on the value of their QVAR purchases relative to all valid claims filed. The more claims submitted, the smaller each individual payment. Third-party payors share the remaining 79.3%.
What is the deadline to file a claim?
July 31, 2026. Claims must be submitted online or postmarked by that date. Missing the deadline means no payment.
What if I want to opt out or object instead?
Both the opt-out (exclusion) and objection deadlines are June 15, 2026. If you exclude yourself, you give up your right to a settlement payment but retain the right to sue Teva separately. If you object, you are still a class member and can still file a claim.
Do I need receipts or proof of purchase to file?
Individual consumers are not explicitly required to submit documentation, but your claim form will ask for information about your purchases. Third-party payors must provide supporting documentation. Keep any pharmacy records, insurance statements, or receipts you have, and review the claim form instructions on the official site for your specific situation.
Is this settlement about whether QVAR is safe or effective?
No. This case is entirely about pricing and market competition -- specifically, whether Teva's patent strategies blocked cheaper generic alternatives and caused consumers and health plans to overpay. The safety and effectiveness of QVAR and QVAR Redihaler are not at issue.
When will payments go out?
Not until the Court grants final approval at or after the August 5, 2026 fairness hearing, and any appeals are resolved. That process can take several months. Check qvarantitrustsettlement.com for updates.
Use the official website
Always confirm details on the official site. If something feels off, stop and verify before sharing personal info.
Info only. Verify details on the official site. Not legal, financial, or tax advice. Legal
Related guides
Avg. MSRP (1 product) or full refund up to 3 products
Deadline: Jul 06, 2026
Tom's of Maine toothpaste settlement -- refund with no receipt required
Turns out "natural" is easier to put on a label than it is to defend in federal court. A $2.9 million settlement covers …
Pro-rata share of $5.55M
Deadline: Jul 10, 2026
Metformin NDMA contamination class action settlement
Teva, Granules, and Heritage have agreed to a combined $5.55 million settlement over claims their generic metformin drug…
Pro rata share of $9M voucher fund
Deadline: Jul 17, 2026
Ashley Furniture fiberglass mattress settlement -- $9M fund, file by July 17
Ashley, Nectar, DreamCloud, and Siena mattresses allegedly contained fiberglass fire retardants that could escape throug…
Share this: